- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02019953
Effects of Health Promoting Programs on Cardiovascular Disease Risk
Effects of Health-Promoting Programs on Cardiovascular Disease Risk: JHS
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The project is designed to achieve five specific aims: (1) To determine the feasibility of attracting African Americans into Health Promotion Research studies;(2) To determine whether clinically recorded information can be used as a guide for recruitment inclusion in Health Promotion Studies from an active epidemiological research cohort;(3) To measure the ability to retain African Americans recruited into Health Promotion Studies from an active research cohort;(4) To measure the adherence to various protocols within a Health promotion Study; and(5) To provide informed estimates of effect sizes for designing future Health Promotion Research.
A total of 375 study participants from the Jackson Heart Study (JHS) cohort, all of whom are African American, will be randomly assigned to one of five, equally-sized study arms: (1) practicing yoga three times per week; (2) practicing yoga two times per week; (3) practicing yoga one time per week; (4) walking briskly three times per week; and (5) attending a weekly healthy lifestyles class.
All study arms will include a 24-week intervention. In addition, participants will have a total of four clinical visits with members of the study team baseline, 12 weeks, 24 weeks, and 48 weeks) in which the following measures will be recorded:
- Systolic and diastolic blood pressure and heart rates
- Highly sensitive C-reactive protein (hsCRP) - serum, fibrinogen - plasma (sodium citrate), homocysteine (plasma), and interleukin-6 levels (IL-6) (serum).
- Fasting total cholesterol, low density (LDL), direct high density lipoprotein (HDL), and triglyceride levels - all serum
- HbA1c level
- BMI, waist circumference
- Medication and supplement use and dosages
- Results of a study survey designed to measure participants' changes in their reported health-related quality of life, perceived stress, health behaviors, sleep patterns, and impact of pain on everyday life
In addition, we will also record systolic and diastolic blood pressure and heart rates before and after each intervention session for all five study arms.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Mississippi
-
Jackson, Mississippi, United States, 39216
- University of Mississippi Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- This study includes only one inclusion criterion: to participate in this study, one needs to be a member of the Jackson Heart Study cohort.
Exclusion Criteria:
1. Newly diagnosed (within the last six weeks) with a myocardial infarction, cerebrovascular disease, atrial fibrillation, cardiomyopathy, valvular heart disease, fatal cardiac arrhythmia, severe systolic and diastolic heart failure, uncontrolled COPD, uncontrolled moderate to severe hypertension, or a recent recipient of a pacemaker, and/or
2. Change in blood pressure medicine or lipid-lowering medication up to 30 days prior to or plans for a change in the 30 days after enrollment in the study, and/or
3. Already practicing yoga at least once per week or walking briskly for one hour at least three times per week, and/or
4. Inability to attend protocol sessions, and/or
5. Diagnosis of an underlying medical illness that might be considered by the principal investigator to potentially impair one's safety or ability to complete the study protocol (example could possibly include uncontrolled asthma), and/or
6. Current use of a prescription regimen that might be considered by the principal investigator to potentially impair one's safety or ability to complete the study protocol (examples could possibly include use of sedatives or other drugs that could affect a participant's ability to participate in any of the study arms).
7. Pregnant or planning to become pregnant in the next six (6) months.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Yoga 3 times per week
Yoga participation 3 x per week for 24 weeks; 48 week follow-up.
|
The yoga intervention, which is taught based on Hatha yoga, will be offered to study participants in Study Arms 1, 2, and 3, is a combination of asanas (poses), pranayams (breathing exercises), and meditation.
Blood pressure and heart rate measurements are taken before and after each session.
|
Other: Yoga 2 times per week
Yoga participation 2 x per week for 24 weeks; 48 week follow-up
|
The yoga intervention, which is taught based on Hatha yoga, will be offered to study participants in Study Arms 1, 2, and 3, is a combination of asanas (poses), pranayams (breathing exercises), and meditation.
Blood pressure and heart rate measurements are taken before and after each session.
|
Other: Yoga 1 time per week
Yoga participation 1 x per week for 24 weeks; 48 week follow-up
|
The yoga intervention, which is taught based on Hatha yoga, will be offered to study participants in Study Arms 1, 2, and 3, is a combination of asanas (poses), pranayams (breathing exercises), and meditation.
Blood pressure and heart rate measurements are taken before and after each session.
|
Other: Walking 3 times per week
Walking 3x per week for 24 weeks; 48 week follow-up
|
The walking intervention, which is Study Arm 4 includes, three guided walking sessions per week for 24 weeks.
Each class is an hour in length and will include a minimum of 30 minutes of walking at the equivalent of a minimum of three miles per hour.
Each session includes a ten-minute warm-up and ten-minute cool-down period of some stretches and walking at a leisurely pace.
Blood pressure and heart rate measurements are taken before and after each session.
|
Other: Healthy Lifestyles Education
Healthy Lifestyles Education Participation 1 x per week for 24 weeks; 48 week follow-up
|
Participants randomly assigned to the fifth study arm attend one 60-minute healthy lifestyles class per week for 24 weeks.
The Healthy Lifestyles curriculum includes 24 independent lesson modules, which allows participants to begin their intervention at any time during the course schedule.
Blood pressure and heart rate measurements are taken before and after each session.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Primary outcomes for this feasibility study will focus on composite measures for recruitment, retention, and the reasons for refusal or dropout.
Time Frame: Bi-annual for up to 52 weeks after enrollment
|
Primary outcomes for this feasibility study will focus on measures for recruitment, retention, and the reasons for refusal or dropout, and consist of (1) agreement to participate in the study (recruitment); (2) reasons for participating/not-participating; (3) dropout, defined as a monotone missingness pattern of stopping participation before completion of the study; (4) reasons for discontinuation/dropout; (5) attendance, defined as the potentially non-monotone pattern of coming to the scheduled study session; and (6) adherence, defined as attending and completing the scheduled sessions and clinical visits.
|
Bi-annual for up to 52 weeks after enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in participants' hypertension profiles.
Time Frame: 48 weeks
|
Defined using measures of their systolic and diastolic blood pressure
|
48 weeks
|
Changes in participants' inflammation markers
Time Frame: 48 weeks
|
Defined using measures of participants' hsCRP, fibrinogen, homocysteine, and interleukin-6 levels.
|
48 weeks
|
Changes in participants' lipids profiles.
Time Frame: 48 weeks
|
Defined as using measures of participants' fasting total cholesterol, LDL, HDL, and triglycerides.
|
48 weeks
|
Changes in participants' HbA1c levels.
Time Frame: 48 weeks
|
Changes in participants' HbA1c levels.
|
48 weeks
|
Changes in participants' reported health-related quality of life.
Time Frame: 48 weeks
|
Quality of life measured as measured by perceived stress, health behaviors, sleep patterns, and impact of pain on everyday life.
|
48 weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: Gailen D Marshall, MD, PhD, University of Mississippi Medical Center
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2010-0057
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Disease
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedCardiovascular Disease | Inflammatory DiseaseUnited States
-
Morehouse School of MedicineNot yet recruiting
-
Yonsei UniversityRecruitingCardiovascular DiseaseKorea, Republic of
-
Nanjing Medical UniversityNot yet recruitingCardiovascular Disease
-
National Human Genome Research Institute (NHGRI)Active, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruiting
-
AmgenCompletedCardiovascular DiseaseUnited States, Australia
-
VA Office of Research and DevelopmentEnrolling by invitationCardiovascular DiseaseUnited States
Clinical Trials on Yoga
-
Universität Duisburg-EssenCompleted
-
University of Texas at AustinCompleted
-
Adiyaman University Research HospitalCompletedDepression | Stress | Anxiety | Psychological ResilienceTurkey
-
NMP Medical Research InstituteYog-Kulam; Department of Zoology, University of Rajasthan, IndiaCompleted
-
NMP Medical Research InstituteWarwick Research Services; Yog-KulamCompleted
-
Northwestern UniversityCompleted
-
University of MinnesotaCompleted
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedDepression | Pain | Breast Cancer | FatigueUnited States
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)Active, not recruitingProstate CarcinomaUnited States
-
Manhattan Physical Medicine and Rehabilitation,...New York UniversityCompleted